Author:
Buesa J.M.,Mouridsen H.T.,van Oosterom A.T.,Verweij J.,Wagener T.,Steward W.,Poveda A.,Vestlev P.M.,Thomas D.,Sylvester R.
Reference7 articles.
1. Role of DTIC (NSC-45388) in the chemotherapy of sarcomas;Gottlieb;Cancer Treat Rep,1976
2. Phase I trial of intermittent high-dose Dacarbazine;Buesa;Cancer Treat Rep,1984
3. Handbook for reporting results of cancer treatment. W.H.O. offset publication no. 48,1979
4. DTIC therapy in metastatic malignant melanoma: a simplified dose schedule;Pritchard;Cancer Treat Rep,1980
5. van Oosterom AT, Bramwell VHC, Mouridsen HT et al. Management of soft tissue and bone sarcomas. Van Oosterom AT, and van Unnik JAM, eds. New York, Raven Press, 1986. Review of the E.O.R.T.C. soft tissue and bone sarcoma group's phase II studies in advanced soft tissue sarcomas, 161-7.
Cited by
96 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献